NCT01748162

Brief Summary

Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential triggers (certain foods, environmental allergens, etc), and should episodes of croup recur they are treated with a short course of oral steroids. The purpose of this study is to compare two safe and clinically appropriate methods for treating recurrent croup, daily inhaled steroids versus observation with oral steroids on an as needed basis, to see if either is useful in preventing future episodes of croup.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 12, 2012

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

November 13, 2017

Completed
Last Updated

November 13, 2017

Status Verified

November 1, 2017

Enrollment Period

1.7 years

First QC Date

October 31, 2012

Results QC Date

October 2, 2017

Last Update Submit

November 1, 2017

Conditions

Keywords

crouprecurrent croupbarky cough

Outcome Measures

Primary Outcomes (1)

  • Quantity of Recurrent Episodes

    Quantity of recurrent croup episodes experienced over a 1 year period by each participating subject.

    1 year

Secondary Outcomes (1)

  • Severity of Croup Episodes

    1 year

Study Arms (2)

Inhaled steroids

EXPERIMENTAL

Daily inhaled steroids. Fluticasone 2 puffs inhaled orally twice daily for six months.

Drug: Fluticasone

Oral control

ACTIVE COMPARATOR

Patient and clinician observation with short term oral prednisolone as needed. Offered at 1mg/kg (body weight) daily dosing for symptomatic treatment on as needed basis for three days, but may be modified per managing physician's discretion.

Drug: Prednisolone IF needed

Interventions

Daily inhaled steroids. Fluticasone 2 puffs inhaled orally twice daily for six months.

Inhaled steroids
Oral control

Eligibility Criteria

Age6 Months - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric population: 6 months to 15 years of age
  • or more episodes of croup in 12 month period
  • croup defined as acute onset inspiratory stridor, barking cough, with respiratory distress.

You may not qualify if:

  • Grade 3 or 4 subglottic stenosis
  • Subglottic hemangioma
  • Posterior laryngeal cleft
  • Recurrent respiratory papillomatosis
  • External compression (Innominate artery compression, mediastinal mass, (double aortic arch, etc)
  • Symptoms or signs suggesting another cause of stridor, such as epiglottitis, bacterial tracheitis, or supraglottic foreign body
  • Tracheomalacia/ bronchomalacia severe enough to cause respiratory distress
  • Current steroid therapy for previously diagnosed condition, i.e. reactive airway disease.
  • Other medical conditions necessitating chronic steroid utilization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Related Links

MeSH Terms

Conditions

Croup

Interventions

Fluticasone

Condition Hierarchy (Ancestors)

LaryngitisLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

AndrostadienesAndrostenesAndrostanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Results Point of Contact

Title
Dr. David J. Brown
Organization
University of Michigan

Study Officials

  • David J Brown, MD

    University of Michigan Department of Otolaryngology-Head & Neck Surgery

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Otorhinolaryngology

Study Record Dates

First Submitted

October 31, 2012

First Posted

December 12, 2012

Study Start

September 1, 2012

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

November 13, 2017

Results First Posted

November 13, 2017

Record last verified: 2017-11

Locations